Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease
This study is currently recruiting participants.
Verified by Bayside Health, September 2005
Sponsors and Collaborators: Bayside Health
The Alfred
Information provided by: Bayside Health
ClinicalTrials.gov Identifier: NCT00163696
  Purpose

The researchers are investigating a novel technique, the multi breath nitrogen washout technique, to measure airway changes in various respiratory diseases.


Condition
Cystic Fibrosis
Asthma
Bronchiolitis Obliterans
Lung Transplantation

Genetics Home Reference related topics: cystic fibrosis
MedlinePlus related topics: Asthma Cystic Fibrosis Lung Transplantation
U.S. FDA Resources
Study Type: Observational
Study Design: Natural History, Cross-Sectional, Defined Population, Prospective Study
Official Title: Measurements of Inhomogeneity of the Small Airway With Patients With Cystic Fibrosis, Asthma and Bronchiolitis Obliterans Syndrome (Post Transplant) Using the Multi Breath Nitrogen Washout Technique

Further study details as provided by Bayside Health:

Estimated Enrollment: 90
Study Start Date: September 2004
Detailed Description:

It is well documented that there are significant ventilatory changes in respiratory diseases such as cystic fibrosis, asthma and the onset of bronchiolitis obliterans syndrome (BOS) following chronic rejection of lung transplantation. At present, we use measures such as spirometry and lung biopsies to determine the changes of airway function and disease severity. Our aim is to develop a novel technique called the multi breath nitrogen washout (MBNW) which we believe is able to measure the inhomogeneity of ventilation in both the larger airways (conductive region, generation 1 - 16) as well as the smaller airways (acinar region 17 - 23). Our belief is that these measurements are much more subtle than current techniques and will be more sensitive in measuring large and small airway changes in disease. The MBNW can also give us an insight as to which particular zones of the lung are affected in differing respiratory disease. For example, it is believed that BOS begins at the distal portion of the lung (acinar region) and proceeds towards the proximal zone (conductive). However, at present no current techniques can differentiate between damage to the acinar zone and the conductive zone or indeed accurately measure small airway (acinar zone) function. We believe the the MBNW has the capacity to do so.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Doctor diagnosed cystic fibrosis, asthma
  • Lung transplant recipient

Exclusion Criteria:

  • Smoke history of less than 10 pack years
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00163696

Contacts
Contact: Bruce Thompson ++61 3 9276 3476 b.thompson@alfred.org.au

Locations
Australia, Victoria
Alfred Hospital Recruiting
Melbourne, Victoria, Australia, 3004
Contact: Bruce Thompson     ++61 3 9276 3476     b.thompson@alfred.org.au    
Sponsors and Collaborators
Bayside Health
The Alfred
Investigators
Principal Investigator: Bruce Thompson Head of Physiology Services, Alfred Hospital
  More Information

Study ID Numbers: MBNW alfred
Study First Received: September 11, 2005
Last Updated: July 25, 2007
ClinicalTrials.gov Identifier: NCT00163696  
Health Authority: Australia: National Health and Medical Research Council

Keywords provided by Bayside Health:
MBNW
Ventilation
small airways
Lung Transplant recipients (Bronchiolitis Obliterans syndrome)

Study placed in the following topic categories:
Lung Diseases, Interstitial
Fibrosis
Bronchiolitis
Respiration Disorders
Asthma
Bronchiolitis Obliterans
Lung Diseases, Obstructive
Hypersensitivity
Digestive System Diseases
Genetic Diseases, Inborn
Respiratory Tract Infections
Cystic Fibrosis
Respiratory Tract Diseases
Lung Diseases
Hypersensitivity, Immediate
Infant, Newborn, Diseases
Pancreatic Diseases
Bronchitis
Cystic fibrosis
Respiratory Hypersensitivity

Additional relevant MeSH terms:
Pathologic Processes
Immune System Diseases
Bronchial Diseases

ClinicalTrials.gov processed this record on January 15, 2009